SAHA (Vorinostat) Corrects Inhibitory Synaptic Deficits Caused by Missense Epilepsy Mutations to the GABAA Receptor γ2 Subunit.

MLA

Durisic, Nela, et al. “SAHA (Vorinostat) Corrects Inhibitory Synaptic Deficits Caused by Missense Epilepsy Mutations to the GABAA Receptor Γ2 Subunit.” Frontiers in Molecular Neuroscience, Mar. 2018, p. 1–N.PAG. EBSCOhost, https://doi.org/10.3389/fnmol.2018.00089.

APA

Durisic, N., Keramidas, A., Dixon, C. L., & Lynch, J. W. (2018). SAHA (Vorinostat) Corrects Inhibitory Synaptic Deficits Caused by Missense Epilepsy Mutations to the GABAA Receptor γ2 Subunit. Frontiers in Molecular Neuroscience, 1–N.PAG. https://doi.org/10.3389/fnmol.2018.00089

Chicago

Durisic, Nela, Angelo Keramidas, Christine L. Dixon, and Joseph W. Lynch. 2018. “SAHA (Vorinostat) Corrects Inhibitory Synaptic Deficits Caused by Missense Epilepsy Mutations to the GABAA Receptor Γ2 Subunit.” Frontiers in Molecular Neuroscience, March, 1–N.PAG. doi:10.3389/fnmol.2018.00089.